Sight Sciences Inc (SGHT)
Sight Sciences, Inc. is a healthcare company focused on ophthalmic medical devices for eye disease treatment. Through its Surgical Glaucoma and Dry Eye segments, the company develops and commercializes both surgical and nonsurgical products used by eye care professionals. Its portfolio includes the OMNI family of products, including OMNI Ergo and OMNI EDGE, as well as the SION device and the TearCare system. These products are used in procedures related to glaucoma and evaporative dry eye associated with meibomian gland disease. Sight Sciences serves hospitals, medical centers, ophthalmologists, and optometrists through direct sales representatives and distributors. The company was incorporated in 2010 and is based in Menlo Park, California.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-SGHT
|
$5.34
|
-33.4% Downside
|
Overvalued
|
$9
|
12.2% Upside
|
Fair
|
Fair
|
0.0%
|
November 5, 2026
|
8.4x
|
5.3x
|
441.8 M
|
404 M
|
8.6%
|
64.6%
|
0.9
|
78.4%
|
